MedPath

Epidemiology of Acute Respiratory Distress Syndrome in Chinese ICUs

Completed
Conditions
Acute Respiratory Distress Syndrome
Registration Number
NCT02490215
Lead Sponsor
Peking Union Medical College Hospital
Brief Summary

The acute respiratory distress syndrome(ARDS)has a high morbidity and mortality in patients admitted to intensive care units(ICUs). It represents a significant public health issue. No large nationwide, multicenters study of ARDS has been conducted in China. The purposes of this study are to analyse: 1)the incidence and outcomes of ARDS in ICU; 2) factors associated the mortality ; and 3) risk factors for development of ARDS .

Detailed Description

All patients admitted to the participating ICUs during a 6-month period(from January 1, 2015 to July 1,2015 ) will be screened at ICU admission and daily for the occurrence of ARDS ( AECC criteria) for a maximum of 28 days after ICU admission.

Data collection:

1. For all patients, Demographic characteristics, admission category, the patient source intervention during ICU , APACHEII , SOFA score and discharge information will be collected

2. For patients with ARDS, data about ABG , parameters of MV, hemodynamic on day0 to day7 and last day of MV will be collected.

3. For patients without ARDS at ICU admission, data about risk factor for ARDS ,such as LIPS score, parameters of MV , and fluid balance on ICU day0 to day7 will be collected.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
2530
Inclusion Criteria

all patients age >18 yrs admitted to 24 participating ICUs

Exclusion Criteria

No patients should be excluded (regardless of age, underlying disease, life expectancy, etc).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
incidence of acute respiratory distress syndrome (ARDS)from ICU admission to 28-day of ICU stay

incidence of ARDS = the number of patients developing ARDS during ICU / the total number of patients admitted to ICU

Secondary Outcome Measures
NameTimeMethod
ICU mortality of patients with ARDSfollowed up to 3 months after inclusion or to ICU discharge, whichever occurred first
hospital mortality of patients with ARDSfollowed up to 3 months after inclusion or to hospital discharge, whichever occurred first

Trial Locations

Locations (26)

MICU, Peking union medical college hospital

🇨🇳

Beijing, Beijing, China

Beijing Hospital of ministry of Health

🇨🇳

Beijing, Beijing, China

Department of Critical Care Medicine, Fuxing Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

General ICU, Beijing Tongren Hospital, Capital Medical University

🇨🇳

Beijing, Beijing, China

Peking University People's Hospital

🇨🇳

Beijing, Beijing, China

China-Japan Friendship Hospital

🇨🇳

Beijng, Beijing, China

Department of Emergency and Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University

🇨🇳

ChongQing, Chongqing, China

The First Affiliated Hospital of Fujian Medical University

🇨🇳

Fuzhou, Fujian, China

Department of CriticalCare Medicine, Guangdong General Hospital

🇨🇳

Guangzhou, Guangdong, China

Department of Critical Care Medicine, Hainan Provincial People's Hospital

🇨🇳

HaiKou, Hainan, China

Scroll for more (16 remaining)
MICU, Peking union medical college hospital
🇨🇳Beijing, Beijing, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.